Glucose Goal in Pregnant Patients in ICU
For critically ill pregnant patients in the ICU, target blood glucose ≤180 mg/dL, initiating insulin when two consecutive values exceed 180 mg/dL, using the same approach as for non-pregnant critically ill patients.
Rationale and Evidence
The available evidence does not provide pregnancy-specific glucose targets for critically ill patients requiring ICU care. The Surviving Sepsis Campaign guidelines 1, 2, 1, 2 and Society of Critical Care Medicine guidelines 3 establish clear targets for critically ill adults but do not address pregnancy as a distinct population. Meanwhile, pregnancy-specific guidelines 4, 5 focus on outpatient or non-critically ill pregnant patients with different physiologic states.
Recommended Approach
Target Range
- Upper limit: ≤180 mg/dL (strong recommendation from multiple critical care guidelines) 1
- Initiate insulin: When two consecutive glucose values >180 mg/dL 1
- Avoid intensive targets <110 mg/dL: The NICE-SUGAR trial demonstrated increased mortality with intensive control (81-108 mg/dL) compared to conventional control (≤180 mg/dL) 6, and meta-analyses confirm 4-9 fold increased hypoglycemia risk without mortality benefit 7, 8
Critical Distinction from Non-ICU Pregnancy Targets
This is fundamentally different from outpatient pregnancy targets. Non-critically ill pregnant patients target preprandial glucose ≤95 mg/dL and 1-hour postprandial ≤140 mg/dL 5. However, these targets are inappropriate for critically ill patients because:
- Hypoglycemia risk: Intensive targets (80-110 mg/dL) cause severe hypoglycemia in 6-29% of critically ill patients 1
- Mortality risk: The landmark NICE-SUGAR trial showed 27.5% mortality with intensive control vs 24.9% with conventional control (≤180 mg/dL) 6
- Physiologic differences: Critical illness induces insulin resistance and stress hyperglycemia distinct from pregnancy-related glucose metabolism 1
Implementation Protocol
Monitoring
- Every 1-2 hours until glucose and insulin rates stabilize 1
- Every 4 hours thereafter once stable 1
- Use arterial blood if arterial catheter present (more accurate than capillary) 1, 9
- Interpret point-of-care capillary testing with caution: Can be inaccurate in critically ill patients, especially with hypotension, anemia, or vasopressor use 1
Insulin Administration
- Intravenous insulin infusion is the preferred route for critically ill patients 10, 3
- Use a protocolized approach with explicit clinical decision support to minimize hypoglycemia 3
- Avoid insulin boluses which increase glucose variability and hypoglycemia risk 11
Key Safety Considerations
Hypoglycemia Prevention
- Modify regimen when glucose <100 mg/dL 10
- Required intervention when <70 mg/dL 10
- Severe hypoglycemia (≤40 mg/dL) dramatically increases with intensive control 1
- Monitor nutrition delivery: Continuation of insulin with cessation of nutrition is a major hypoglycemia risk factor 1
Common Pitfalls to Avoid
- Do not apply outpatient pregnancy targets to ICU patients - this creates dangerous hypoglycemia risk
- Do not target <110 mg/dL - no mortality benefit and substantially increased harm 1, 6
- Do not rely solely on capillary glucose meters in hemodynamically unstable patients - use arterial blood gas analyzers or central laboratory 9, 1
- Do not use intermittent subcutaneous insulin in unstable critically ill patients - IV infusion provides better control 10
Special Circumstances
While stricter ranges (110-140 mg/dL) may be appropriate for selected stable patients if achievable without hypoglycemia 1, this should not be the default approach. The pregnant patient's critical illness takes precedence over pregnancy-specific glycemic goals until she is stable enough for transfer out of the ICU setting.
The priority is preventing both severe hyperglycemia (>180 mg/dL) and hypoglycemia, as both are associated with increased mortality in critically ill patients 1, 3, 7. Network meta-analyses confirm that 144-180 mg/dL provides the best balance of mortality reduction and hypoglycemia avoidance 7, 8.